即將上市(暗盤交易時段:今日16:15-18:30)
| 公司名稱▼
/
代號▼ | 行業 | 招股價 | 每手股數 | 入場費 | 招股截止日 | 暗盤日期▼ | 上市日期▲ |
| 華潤飲料(控股) 02460.HK | 非酒精飲料 | 13.50-14.50 | 200 | 2,929 | 2024/10/18 |
供應商不支援 | 2024/10/23 |
公司名稱/代號 | 現價2 | 今日升跌▼ | 十天升跌▼ | 市值▼ | 市盈率 (倍)▼ | 市帳率 (倍)▼ | 派息比率 (%)▼ | 股東權益 回報率(%)▼ | 經營 利潤率(%)▼ | 總債項/ 股東權益(%)▼ | 選擇比較 |
大健康國際 02211.HK | 0.110 | 0.000% | +54.93% | 8.81千萬 | 171.35 | 0.23 | N/A | 0.12% | 0.01% | 20.02% | |
京東健康 06618.HK | 28.900 | +3.957% | -8.54% | 922.04億 | 38.21 | 1.70 | N/A | 4.34% | 5.16% | 0.44% | |
京東健康-R 86618.HK | 26.350 | +4.771% | -7.38% | 840.69億 | 38.19 | 1.70 | N/A | 4.34% | 5.16% | 0.44% | |
阿里健康 00241.HK | 4.230 | +0.955% | +2.67% | 680.68億 | 62.35 | 4.34 | N/A | 6.07% | 3.50% | 0.56% | |
國藥控股 01099.HK | 20.200 | 0.000% | -0.25% | 271.05億 | 6.35 | 0.77 | 30.000% | 12.14% | 3.39% | 98.93% | |
藥師幫 09885.HK | 7.220 | -2.432% | +1.69% | 46.50億 | N/A | 2.20 | N/A | -166.13% | -18.64% | 10.92% | |
思派健康 00314.HK | 5.300 | -0.563% | -10.62% | 40.45億 | N/A | 2.27 | N/A | -15.80% | -5.20% | 4.17% | |
滿貫集團 03390.HK | 3.670 | 0.000% | -0.81% | 29.36億 | 9.66 | 5.48 | 18.421% | 55.45% | 28.08% | 38.45% | |
上海先鋒控股 01345.HK | 2.100 | 0.000% | +0.48% | 26.41億 | 15.96 | 2.39 | 36.578% | 14.48% | 11.54% | 7.35% | |
創美藥業 02289.HK | 8.090 | 0.000% | -8.07% | 8.74億 | 15.52 | 1.33 | 63.105% | 8.59% | 1.50% | 104.54% | |
叮噹健康 09886.HK | 0.620 | 0.000% | +16.98% | 8.32億 | N/A | 0.37 | N/A | -11.08% | -4.50% | 6.88% | |
金活醫藥集團 01110.HK | 0.530 | -1.852% | +1.92% | 3.30億 | 7.51 | 0.49 | 47.879% | 6.15% | 8.97% | 57.25% | |
CLSA PREMIUM 06877.HK | 0.110 | -8.333% | +44.74% | 2.24億 | 22.92 | 0.93 | N/A | 4.10% | 7.30% | 0.00% | |
澳至尊 02031.HK | 0.242 | +0.833% | -2.81% | 1.84億 | 6.01 | 1.04 | 49.628% | 17.21% | 13.95% | 11.67% | |
順騰國際控股 00932.HK | 0.041 | 0.000% | +13.89% | 1.27億 | 205.00 | 0.74 | N/A | 0.33% | 5.24% | 85.66% | |
新銳醫藥 06108.HK | 0.051 | 0.000% | +21.43% | 8.53千萬 | N/A | 0.18 | N/A | -4.62% | -44.55% | 0.06% | |
百信國際 00574.HK | 0.051 | 0.000% | +41.67% | 7.52千萬 | 29.08 | N/A | N/A | -2.02% | 2.63% | -142.96% | |
|